These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 21153402)
1. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Hall MW; Knatz NL; Vetterly C; Tomarello S; Wewers MD; Volk HD; Carcillo JA Intensive Care Med; 2011 Mar; 37(3):525-32. PubMed ID: 21153402 [TBL] [Abstract][Full Text] [Related]
2. Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis. Bline KE; Moore-Clingenpeel M; Hensley J; Steele L; Greathouse K; Anglim L; Hanson-Huber L; Nateri J; Muszynski JA; Ramilo O; Hall MW Crit Care; 2020 Sep; 24(1):545. PubMed ID: 32887651 [TBL] [Abstract][Full Text] [Related]
3. Immunoparalysis in critically ill children. Neves FL; Amaral MNGA; da Silva SFD; Silva IMM; Laranjeira PMDS; Pinto CRJ; Paiva AA; Dias ASDS; Coelho MLACV Immunology; 2023 Apr; 168(4):597-609. PubMed ID: 36279244 [TBL] [Abstract][Full Text] [Related]
4. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis. Joshi I; Carney WP; Rock EP Front Immunol; 2023; 14():1130214. PubMed ID: 36825018 [TBL] [Abstract][Full Text] [Related]
5. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Rosenbloom AJ; Linden PK; Dorrance A; Penkosky N; Cohen-Melamed MH; Pinsky MR Chest; 2005 Jun; 127(6):2139-50. PubMed ID: 15947332 [TBL] [Abstract][Full Text] [Related]
6. The Design of Nested Adaptive Clinical Trials of Multiple Organ Dysfunction Syndrome Children in a Single Study. VanBuren JM; Hall M; Zuppa AF; Mourani PM; Carcillo J; Dean JM; Watt K; Holubkov R Pediatr Crit Care Med; 2023 Dec; 24(12):e635-e646. PubMed ID: 37498156 [TBL] [Abstract][Full Text] [Related]
7. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality. Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563 [TBL] [Abstract][Full Text] [Related]
8. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Nierhaus A; Montag B; Timmler N; Frings DP; Gutensohn K; Jung R; Schneider CG; Pothmann W; Brassel AK; Schulte Am Esch J Intensive Care Med; 2003 Apr; 29(4):646-51. PubMed ID: 12595977 [TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Profiles in Children With Septic Shock With or Without Immunoparalysis. Snyder A; Jedreski K; Fitch J; Wijeratne S; Wetzel A; Hensley J; Flowers M; Bline K; Hall MW; Muszynski JA Front Immunol; 2021; 12():733834. PubMed ID: 34659221 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430 [TBL] [Abstract][Full Text] [Related]
12. Early Immune Function and Duration of Organ Dysfunction in Critically III Children with Sepsis. Muszynski JA; Nofziger R; Moore-Clingenpeel M; Greathouse K; Anglim L; Steele L; Hensley J; Hanson-Huber L; Nateri J; Ramilo O; Hall MW Am J Respir Crit Care Med; 2018 Aug; 198(3):361-369. PubMed ID: 29470918 [TBL] [Abstract][Full Text] [Related]
13. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Kylanpaa ML; Mentula P; Kemppainen E; Puolakkainen P; Aittomaki S; Silvennoinen O; Haapiainen R; Repo H Pancreas; 2005 Jul; 31(1):23-7. PubMed ID: 15968243 [TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022 [TBL] [Abstract][Full Text] [Related]
15. Innate immune function predicts the development of nosocomial infection in critically injured children. Muszynski JA; Nofziger R; Greathouse K; Nateri J; Hanson-Huber L; Steele L; Nicol K; Groner JI; Besner GE; Raffel C; Geyer S; El-Assal O; Hall MW Shock; 2014 Oct; 42(4):313-21. PubMed ID: 24978895 [TBL] [Abstract][Full Text] [Related]
18. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Leentjens J; Kox M; Koch RM; Preijers F; Joosten LA; van der Hoeven JG; Netea MG; Pickkers P Am J Respir Crit Care Med; 2012 Nov; 186(9):838-45. PubMed ID: 22822024 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Bo L; Wang F; Zhu J; Li J; Deng X Crit Care; 2011; 15(1):R58. PubMed ID: 21310070 [TBL] [Abstract][Full Text] [Related]
20. Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome. Carcillo JA; Halstead ES; Hall MW; Nguyen TC; Reeder R; Aneja R; Shakoory B; Simon D; Pediatr Crit Care Med; 2017 Jun; 18(6):513-523. PubMed ID: 28410274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]